Delivery Order SPE2DE24D0021-SPE2D625F4Q2Z
- Not listed
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,076.64 on August 21, 2025, for the procurement of BinaxNow COVID-19 antigen testing kits. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and is funded by the Defense Department's Medical Supply Chain division. Performance will be completed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 28, 2025. This award represents a child contract with no...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,152.00 on April 30, 2025, for the supply of BinaxNOW COVID-19 antigen testing kits. The contract is a fixed-price delivery order with economic price adjustment provisions and is classified as a child contract, indicating it derives from a larger contract vehicle. Performance will be completed by June 2, 2025, at Fisher Scientific's facility in Pittsburgh, Pennsylvania. The award utilized no set-aside designations,...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,176.00 on August 19, 2025, for the supply of BinaxNOW COVID-19 antigen testing kits. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 26, 2025, with performance taking place in Pittsburgh, Pennsylvania. The award was made without a set-aside designation, indicating open competition procurement. The funding agency is the Medical Supply Chain, operating under the...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,322.00 for BinaxNOW COVID-19 antigen testing kits on April 30, 2025, with an ultimate completion date of May 7, 2025. This fixed-price contract with economic price adjustment was issued by the Medical Supply Chain, a defense-oriented federal agency, and will be performed in Pittsburgh, Pennsylvania. As a child contract, this delivery order is part of a larger contracting vehicle, leveraging Fisher Scientific's established...
- The U.S. Medical Supply Chain, a Defense Department component, awarded a $1,546.93 fixed-price delivery order with economic price adjustment to Fisher Scientific Company L.L.C. on May 6, 2025, for BinaxNOW COVID-19 antigen testing kits. The contract is set to be completed by June 6, 2025, with performance taking place in Pittsburgh, Pennsylvania. This delivery order represents a child contract under a larger vehicle and was awarded through open competition with no set-aside designation,...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,470.00 by the Medical Supply Chain, a defense-affiliated federal agency, on June 2, 2025, for the supply of BinaxNOW COVID-19 antigen over-the-counter test kits (12 tests per box, 2 boxes per case). The contract is structured as a fixed-price agreement with economic price adjustment provisions and is set to be completed by June 9, 2025, with performance taking place in Pittsburgh, Pennsylvania. This award represents a...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,540.27 on August 4, 2025, for the procurement of BinaxNOW COVID-19 antigen testing kits. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and is scheduled for completion by August 11, 2025. Performance will take place in Pittsburgh, Pennsylvania. This award represents a child contract under a larger vehicle and was issued without a set-aside designation, reflecting...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,159.12 on November 4, 2025, for the provision of BinaxNow COVID antigen testing kits to support the Department of Defense Medical Supply Chain. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of November 12, 2025. Performance will be executed from Fisher Scientific's location in Pittsburgh, Pennsylvania. This award represents a...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $2,156 to Fisher Scientific Company L.L.C. on November 20, 2025, for the provision of BinaxNOW COVID-19 antigen testing kits. This is a fixed-price delivery order with economic price adjustment provisions, with an ultimate completion date of November 28, 2025. The contract carries no set-aside designation, indicating Fisher Scientific competed for this award in an open procurement environment. Performance will...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $2,205.00 for BinaxNow COVID-19 antigen OTC test kits (12 tests per 2-test case) by the Defense Medical Supply Chain federal agency. The contract, awarded on September 9, 2025, with an ultimate completion date of September 16, 2025, utilizes a fixed price with economic price adjustment pricing structure. The place of performance is Pittsburgh, Pennsylvania. This delivery order represents a child contract, indicating...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F4Q2ZDelivery Order
Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order valued at $5,822.94 on April 24, 2025, for the procurement of BinaxNOW COVID-19 antigen testing kits. The contract, which represents no set-aside designation, will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of May 1, 2025. This delivery order is structured with economic price adjustment provisions and is funded through the Medical Supply Chain, a defense-oriented federal agency. Fisher Scientific, a major supplier of scientific products and laboratory equipment to federal agencies, leverages its extensive capabilities in specialized testing solutions and medical equipment procurement to fulfill this requirement. This award reflects the ongoing federal government's need to maintain pandemic response capabilities through rapid COVID-19 testing infrastructure. As a child contract under a larger vehicle, this delivery order demonstrates Fisher Scientific's continued role as a critical vendor supporting government health and defense initiatives. The company's established track record of supplying laboratory and medical equipment to agencies including the National Institutes of Health, Department of Veterans Affairs, and Department of Defense positions it well to deliver these testing kits within the compressed timeline, with performance completion scheduled for May 1, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 4/24/25 |